UK Stocks-Factors to watch on Dec. 22



Dec 22 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening higher on Wednesday, with futures FFIc1 up 0.28%.

* METRO BANK: The Bank of England's Prudential Regulation Authority has fined Metro Bank METRO.L 5.38 million pounds ($7.13 million) for failures in its regulatory reporting governance and controls, it said.

* TAYLOR WIMPEY: UK's third-largest homebuilder Taylor Wimpey TW.L will drop contract terms that lock leaseholders into rents that double every 10 years, ending a year-long probe into the company by the British competition watchdog, the regulator said.

* PENNON GROUP: British water company Pennon Group PNN.L said it will offer undertakings to the UK's competition regulator by Dec. 31 as part of a review of its deal to acquire Bristol Water BTW_pa.L .

* SYNCONA: Healthcare investment firm Syncona Ltd SYNCS.L said Novartis AG NOVN.S will buy its Gyroscope Therapeutics unit for up to $1.5 billion as the Swiss drugmaker seeks access to the British firm's gene therapy for a blindness-causing disease.

* NATWEST: A unit of NatWest Group NWG.L agreed to pay about $35 million and pleaded guilty to wire and securities fraud in relation to a long-running scheme by some of its traders to manipulate U.S. Treasury debt markets.

* BHP GROUP: BHP Group BHP.AX said it would not match a takeover offer by billionaire Andrew Forrest's Wyloo Metals for Noront Resources Ltd NOT.V , essentially bowing out from a months-long tussle for the Canadian nickel miner.

* RIO TINTO: Rio Tinto Plc RIO.L , RIO.AX said it would buy the Rincon lithium project in Argentina for $825 million as the global miner builds its battery materials business.

* GOLD: Gold prices were stuck in a narrow trading range as market participants headed into year-end holidays, with safe-haven demand fuelled by the rapidly spreading Omicron COVID-19 variant countering a steady improvement in risk appetite.

* OIL: Oil prices were steady, with market players on the lookout for fuel demand pointers amid COVID-19 concerns after Singapore suspended quarantine-free travel and Australia renewed its vaccination push due to a surge in Omicron variant cases.

* A rebound in commodity and travel stocks drove UK shares higher on Tuesday, a day after the market hit a two-week low on concerns that surging cases of COVID-19 variant Omicron would spark fresh restrictions.

* For more on the factors affecting European stocks, please click on:

TODAY'S UK PAPERS

> Financial Times

> Other business headlines


Reporting By Amna Karimi in Bengaluru; Editing by Vinay Dwivedi

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.